The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Levin Arthur A since 2021.
This trader's CIK number is 1181556.
At the time of last reporting, Levin Arthur A was the Officer of Stoke Therapeutics, Inc.. (stock ticker symbol STOK).
Also see all insider trading activities at Stoke Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | STOK | 0 | $0 | 0 | $0 | 2,420 | $0 |
| 2021 | STOK | 0 | $0 | 12,500 | $760,600 | 12,500 | $5,837 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RNA | 0 | $0 | 1,872 | $53,537 | 0 | $0 |
| 2024 | RNA | 0 | $0 | 192,823 | $6,601,311 | 68,323 | $84,720 |
| 2023 | RNA | 0 | $0 | 60,000 | $1,339,900 | 60,000 | $74,400 |
| 2022 | RNA | 0 | $0 | 80,000 | $1,767,653 | 80,000 | $67,069 |
| 2021 | RNA | 0 | $0 | 87,022 | $2,369,672 | 50,000 | $44,356 |
1. Stoke Therapeutics, Inc. (STOK)
2. Avidity Biosciences, Inc. (RNA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-30 | STOK | Option Ex | 1,210 | .00 | 0 |
| 2025-03-31 | STOK | Option Ex | 1,210 | .00 | 0 |
| 2021-03-01 | STOK | Sale | 12,500 | 60.85 | 760,600 |
| 2021-03-01 | STOK | Option Ex | 12,500 | .47 | 5,837 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-21 | RNA | Sale | 1,872 | 28.60 | 53,537 |
| 2024-11-19 | RNA | Option Ex | 3,323 | 1.24 | 4,120 |
| 2024-11-19 | RNA | Sale | 3,323 | 42.12 | 139,971 |
| 2024-10-21 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-10-21 | RNA | Sale | 5,000 | 46.63 | 233,170 |
| 2024-09-19 | RNA | Sale | 5,000 | 45.73 | 228,660 |
| 2024-09-19 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-08-19 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-08-19 | RNA | Sale | 5,000 | 45.19 | 225,945 |
| 2024-07-19 | RNA | Sale | 5,000 | 45.01 | 225,070 |
| 2024-07-19 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-06-20 | RNA | Sale | 5,000 | 37.59 | 187,950 |
| 2024-06-20 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-06-12 | RNA | Sale | 40,000 | 35.07 | 1,402,640 |
| 2024-06-13 | RNA | Sale | 60,000 | 40.08 | 2,404,800 |
| 2024-05-20 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-05-20 | RNA | Sale | 5,000 | 29.90 | 149,480 |
| 2024-04-19 | RNA | Sale | 5,000 | 22.82 | 114,125 |
| 2024-04-19 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-04-03 | RNA | Sale | 20,000 | 27.11 | 542,220 |
| 2024-03-19 | RNA | Option Ex | 5,000 | 1.24 | 6,200 |
| 2024-03-19 | RNA | Sale | 5,000 | 23.97 | 119,850 |
| 2024-03-12 | RNA | Option Ex | 25,000 | 1.24 | 31,000 |
| 2024-03-12 | RNA | Sale | 27,641 | 22.02 | 608,599 |
| 2024-01-22 | RNA | Sale | 1,859 | 10.13 | 18,831 |
| 2023-02-14 | RNA | Option Ex | 10,000 | 1.24 | 12,400 |
| 2023-02-14 | RNA | Sale | 10,000 | 23.93 | 239,310 |
| 2023-01-12 | RNA | Sale | 10,000 | 22.00 | 220,030 |
| 2023-01-12 | RNA | Option Ex | 10,000 | 1.24 | 12,400 |
| 2022-12-29 | RNA | Option Ex | 40,000 | 1.24 | 49,600 |
| 2022-12-29 | RNA | Sale | 40,000 | 22.01 | 880,560 |
| 2022-08-16 | RNA | Sale | 3,499 | 22.08 | 77,257 |
| 2022-08-15 | RNA | Sale | 62,498 | 22.12 | 1,382,330 |
| 2022-08-16 | RNA | Option Ex | 3,499 | 1.24 | 4,338 |
| 2022-08-15 | RNA | Option Ex | 62,498 | .89 | 55,310 |
| 2022-08-12 | RNA | Sale | 14,003 | 22.00 | 308,066 |
| 2022-08-12 | RNA | Option Ex | 14,003 | .53 | 7,421 |
| 2021-11-18 | RNA | Sale | 25,000 | 27.89 | 697,225 |
| 2021-11-18 | RNA | Option Ex | 25,000 | .89 | 22,125 |
| 2021-06-24 | RNA | Option Ex | 100 | 1.24 | 124 |
| 2021-06-25 | RNA | Option Ex | 20,100 | .89 | 17,788 |
| 2021-06-24 | RNA | Sale | 100 | 27.75 | 2,775 |
| 2021-06-25 | RNA | Sale | 20,100 | 28.55 | 573,955 |
| 2021-06-17 | RNA | Sale | 200 | 27.75 | 5,550 |
| 2021-06-17 | RNA | Option Ex | 200 | 1.24 | 248 |
| 2021-06-14 | RNA | Sale | 14,003 | 25.92 | 362,915 |
| 2021-06-15 | RNA | Sale | 23,019 | 26.02 | 599,069 |
| 2021-03-16 | RNA | Option Ex | 4,600 | .89 | 4,071 |
| 2021-03-16 | RNA | Sale | 4,600 | 27.87 | 128,183 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Levin Arthur A (Officer of Stoke Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.